Monday, Apr 6, 2026 · SEC filings

What the smart money revealed on Apr 6

Real insider buys25insiders · $3.78M
Real insider sales42insiders · $48.6M
Fund 13Fs filed20quarterly holdings
Activist 13Ds filed05%+ stakes

423 insider filings came in. We hid 58 planned (10b5-1) sellers and 285 people whose filings were routine, like grants and tax withholding.

group

5 insiders at HMH Holding (HMH) bought $1.48M of stock

Roles: Chief Commercial Officer, CEO, CFO, CTO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 2
$1.48M
trending_up

Shoe Carnival (SCVL) EVP - CFO W Jackson bought $500K

31,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 2
$500K
trending_up

Goldman Sachs BDC (GSBD) Director Carlos Evans bought $451K

50,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 2
$451K
trending_up

Lipocine (LPCN) Director John Higuchi bought $252K

123,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 6
$252K
trending_up

Victoria's Secret & (VSCO) Director Anne Sheehan bought $222K

4,842 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 2
$222K
account_balance

Greenhaven Associates filed its holdings: 27 stocks

Holdings as of Mar 31, 2026. Open the fund to see what it bought and sold.

13F As of Mar 31
$6.07B
account_balance

Washington Trust filed its holdings: 281 stocks

Holdings as of Mar 31, 2026. Open the fund to see what it bought and sold.

13F As of Mar 31
$2.96B
trending_down

Starwood Real Estate Income Trust (SWDR) Director Barry Sternlicht sold $18.6M

Not marked as a planned 10b5-1 sale. Sold 13% of the shares they held directly. Still holds 6.32M shares.

Real sale Form 4 Traded Apr 1
$18.6M
trending_down

Vor Biopharma (VOR) Director Peter Kolchinsky sold $14.5M

Not marked as a planned 10b5-1 sale. Sold 16% of the shares they held directly. Still holds 4.56M shares.

Real sale Form 4 Traded Apr 2–6
$14.5M
trending_down

Chewy (CHWY) General Counsel & Secretary Da-Wai Hu sold $219K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Apr 1
$219K
Show 16 more real buys
Show 39 more real sales
PL Planet Labs PBC · President & CFO Ashley Johnson · Traded Apr 2
$7.02M
ERII Energy Recovery · Director Arve Hanstveit · Traded Apr 2
$1.68M
CRDO Credo Technology Group Holding · Pres & CEO William Brennan · Traded Apr 2–5
$1.25M
LE Lands' End · CEO Andrew McLean · Traded Apr 1
$761K
CRDO Credo Technology Group Holding · COO Yat Lam · Traded Apr 2–5
$645K
SNX TD SYNNEX · CFO David Jordan · Traded Apr 6
$611K
LE Lands' End · PRES LE Licensing Peter Gray · Traded Apr 1
$515K
CRDO Credo Technology Group Holding · CFO Daniel Fleming · Traded Apr 2–5
$499K
AFYA Afya · CEO Virgilio Gibbon · Traded Apr 2–6
$324K
CRDO Credo Technology Group Holding · CTO Chi Cheng · Traded Apr 5
$247K
SWDR Starwood Real Estate Income Trust · Director Austin Nowlin · Traded Apr 1
$232K
LE Lands' End · Director Josephine Linden · Traded Apr 1
$157K
LE Lands' End · CFO and Treasurer Bernard McCRACKEN · Traded Apr 1
$151K
LE Lands' End · Director Robert Galvin · Traded Apr 1
$133K
PRVA Privia Health Group · EVP & CFO David Mountcastle · Traded Apr 2
$116K
AIP Arteris · VP and CFO Nicholas Hawkins · Traded Apr 2
$86K
CDLX Cardlytics · CEO Amit Gupta · Traded Apr 6
$83.1K
LWLG Lightwave Logic · Director Thomas Connelly · Traded Apr 6
$76.7K
OLP One Liberty Properties · Exec.Vice President and COO Lawrence Ricketts · Traded Apr 2
$65.6K
LE Lands' End · President Kym Maas · Traded Apr 1
$64.8K
AIP Arteris · VP and General Counsel Paul Alpern · Traded Apr 2
$64.4K
SWDR Starwood Real Estate Income Trust · Officer Matthew Guttin · Traded Apr 1
$64.3K
SWDR Starwood Real Estate Income Trust · CFO Joseph Nieto · Traded Apr 1
$51K
LE Lands' End · Director Elizabeth Leykum · Traded Apr 1
$42.1K
BCYC Bicycle Therapeutics · CEO Kevin Lee · Traded Apr 2–6
$38K
LE Lands' End · Director John McClain · Traded Apr 1
$37.8K
LE Lands' End · Director Gordon Hartogensis · Traded Apr 1
$33.8K
AIRO AIRO Group · President and COO John Uczekaj · Traded Apr 6
$30.2K
PERI Perion Network · Director Eyal Kaplan · Traded Apr 1
$29.1K
LE Lands' End · EVP Martin Christopher · Traded Apr 1
$23.9K
PERI Perion Network · Director Michael Vorhaus · Traded Apr 1
$21.6K
AMBQ Ambiq Micro · General Counsel Michele Connors · Traded Apr 2
$21.2K
SOGP Sound Group · Director Ming Zhang · Traded Apr 2
$16.9K
PERI Perion Network · Director Joy Marcus · Traded Apr 1
$16.9K
POWI Power Integrations · VP Gagan Jain · Traded Apr 2
$16.3K
LE Lands' End · Director Alicia Parker · Traded Apr 1
$13K
BCYC Bicycle Therapeutics · Chief Scientific Officer Michael Skynner · Traded Apr 2–6
$11.9K
BCYC Bicycle Therapeutics · Chief Prod & Supply Chain OFF Michael Hannay · Traded Apr 2–6
$8.74K
BCYC Bicycle Therapeutics · CFO Travis Thompson · Traded Apr 2–6
$4.44K

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist